Immuno-oncology: where to go in a packed field

Merck, Keytruda, pembrolizumab, cancer, immunotherapy, immuno-oncology

Merck's Keytruda (pembrolizumab) was one of the game-changing breakthroughs for immuno-oncology. Image courtesy of Merck.